ArticleWorld journal of urology2026
Comparison of ultrasonic lithotripsy with Ho:YAG laser lithotripsy during percutaneous nephrolithotomy for 20-40 mm low-hardness renal calculi: a propensity score-matched study.
Article in World journal of urology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
purposeThis study aims to compare the efficacy and safety of ultrasonic lithotripsy (UL) with an integrated suction system versus holmium: yttrium-aluminum-garnet (Ho:YAG) laser lithotripsy during percutaneous nephrolithotomy (PCNL) for treating 20-40 mm low-hardness renal stones using propensity score matching (PSM) analysis.
methodsThis single-center retrospective cohort study included 436 patients undergoing PCNL for 20-40 mm low-hardness stones. PSM balanced baseline characteristics, comparing patients treated with an ultrasonic lithotripsy system equipped with an integrated suction system (UL group, n = 110) and Ho:YAG laser lithotripsy (Ho:YAG group, n = 110) regarding 1-day/1-month stone-free rates (SFR), operative time, and complications.
resultsThe UL group exhibited a significantly higher 1-day SFR (96.36% vs. 85.45%, P = 0.005). The 1-month SFR was numerically higher in the UL group than in the Ho:YAG group (96.36% vs. 90.00%), although the difference did not reach statistical significance (P = 0.061). Complication rates were lower in the UL group (7.27% vs. 22.73%, p = 0.001), particularly for low-grade Clavien I-II events. Postoperative pain (VAS) at 6 h was higher in the UL group (7.24 ± 1.53 vs. 6.67 ± 1.97, p = 0.018), yet comparable at 24/48 hours. Hemoglobin drop, operative time, and hospitalization showed no intergroup differences.
conclusionUL demonstrates superior early SFR and safety for 20-40 mm low-hardness stones, suggesting that it has the potential to facilitate stentless PCNL. Prospective studies are warranted to validate these findings and optimize clinical protocols.
Indexed as
Identifiers
42752701What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.